CBD Co. Inks $712K Deal To End Investors' Securities Suit
By Sarah Jarvis (February 1, 2022, 6:02 PM EST) -- Investors who accused CBD company CV Sciences Inc. of misleading them about a rejected patent application have reached a tentative $712,500 settlement with the business to end their claims, Nevada federal court documents show.
Lead plaintiff Richard Ina, a trustee of the Ina Family Trust, said in a Monday memorandum supporting his motion for preliminary approval of the settlement that the deal comes after three years of hard-fought litigation. He noted that defendants CV Sciences, CEO Joseph D. Dowling, former CEO Michael Mona Jr. and former Chief Operating Officer Michael Mona III deny any wrongdoing.
"The proposed settlement is well within the...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!